Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial
Kennedy R. Lees(University of Graz), John Whitehead(Lancaster City Council), Kjell Asplund(Umeå University), Antonio Carolei, Hans‐Christoph Diener(Essen University Hospital), Stephen M. Davis(The Royal Melbourne Hospital), Jean‐Marc Orgogozo(Unknown), Markku Kaste(University of Helsinki)
Cited by 310
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k
Ischaemic stroke
|Nature Reviews Disease Primers|2019|1.7k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k